Jevtana 60mg/ml Injection Description:
Jevtana 60mg/ml Injection is an anti-cancer medication. It works by damaging the genetic material (DNA) of the cancer cells and stops their growth and multiplication.
Jevtana 60mg/ml Injection is used in the treatment of prostate cancer.
Nausea, Vomiting, Back pain, Weakness, Low blood platelets, Hair loss, Abdominal pain, Decreased white blood cell count, Loss of appetite, Anemia (low number of red blood cells), Diarrhoea, Stomatitis (Inflammation of the mouth), Blood in urine, Constipation, Cough, Altered taste, Breathing difficulty, Decreased white blood cell count (neutrophils).
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Is Jevtana a vesicant or chemotherapeutic drug?
Jevtana is a chemotherapeutic drug (drug used for the management of cancer). It is, however, not a vesicant (drug which causes severe blisters on the skin).
Buy Jevtana 60mg/ml Injection Online From India At Best Price
If you are looking to buy Cabazitaxel (60mg/ml) (1.5 ml in 1 vial) online at affordable prices, then Drugssquare.com is your one-stop solution. Drugssquare is a leading supplier, exporter and retailer of generic & branded prescription drugs in the U.S. and all around the world. From Cancer to Hepatitis, and from AIDS to Kidney Disease, the company delivers medicines for all kinds of complex diseases, with savings of up to 70% or more.
Order Online to Get Jevtana 60mg/ml Injection in –
South East Asia – China, Cambodia, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, Hong Kong, Japan, South Korea.
United Arab Emirates (UAE) – Iran, Saudi Arabia, Jordan.
North America – Venezuela, USA (United States of America), Suriname.
South America – Argentina, Chile, Colombia, Peru, Venezuela.
Europe – Romania, Georgia, Turkey, UK (United Kingdom), Ukraine, Latvia.
Russia CIS – Moldova, Uzbekistan, Kyrgyzstan.
African Countries – Nigeria, Kenya, Morocco, Libya, Zimbabwe.
Other Countries – Malaysia, Egypt, Australia, Italy and New Zealand.
There are no reviews yet.